Lexston Mining Corporation (C:LEXT*CA)

Business Focus: Diversified Mining

May 15, 2024 08:20 am ET

Lexston Mining Corporation Closes Private Placement

Vancouver, British Columbia – TheNewswire - May 15, 2024 - Lexston Mining Corporation (the “Company” or “Lexston”) (CSE: LEXT) (OTC: LEXTF) (Frankfurt: W5G) is pleased to announce that further to its news release dated April 26, 2024, it closed a non-brokered private placement of $419,960 through the issuance of 6,999,333 units at a price of $0.06 per unit (the “Private Placement”). Each unit consists of one common share and one common share purchase warrant. Each common share purchase warrant entitles the holder to purchase one common share at a price of $0.08 for two years from the date o

Apr 26, 2024 06:30 am ET

Lexston Mining Corporation Announces a Private Placement to Raise up to $400,000

Vancouver, British Columbia – TheNewswire - April 26, 2024 - Lexston Mining Corporation (the “Company” or “Lexston”) (CSE:LEXT) (OTC:LEXTF) (Frankfurt:W5G) is pleased to announce a non-brokered private placement to raise gross proceeds of up to $400,000 through the issuance of up to 6,666,666 units at a price of $0.06 per unit (the “Private Placement”). Each unit will consist of one common share and one common share purchase warrant. Each common share purchase warrant will entitle the holder to purchase one common share at a price of $0.08 for two years from the date of issuance.

Apr 16, 2024 09:25 am ET

Issuance of 250,000 Shares Pursuant to the Dory Property Option Agreement

Vancouver, British Columbia – TheNewswire - April 16, 2024 - Lexston Mining Corporation (the “Company”) (CSE:LEXT) (OTC:LEXTF) issued 250,000 common shares to the optionor pursuant to the Dory Property Option Agreement, which was announced by the news releases of the Company dated January 18, 2023 and March 31, 2023.

Feb 21, 2024 07:00 am ET

Lexston Mining Corporation will be applying for Exploration Permits for ITZA and 176 Uranium Projects in the Thelon Basin, Nunavut

Vancouver, British Columbia – TheNewswire -- February 21, 2024. Lexston Mining Corporation (the “Company” or “Lexston”) (CSE: LEXT) (OTC: LEXTF) (Frankfurt: W5G) is pleased to announce that its contractor, Lockett Consultation Services Inc., will be applying for the required exploration permits for the Company’s proposed summer geophysical program at Itza and 176 Projects (the “Properties”) in the Thelon Basin in the Kivalliq Region of Nunavut, occupying an area of 11,350 hectares.

Jan 23, 2024 07:15 am ET

Lexston Mining Corporation Arranges Staking of Additional Mineral Claims in Thelon Basin, Nunavut

Vancouver, British Columbia – TheNewswire -- January 23, 2024. Lexston Mining Corporation (the “Company” or “Lexston”) (CSE:LEXT) (OTC:LEXTF) (Frankfurt:W5G) announces that further to its news releases dated November 27, 2023 and January 10, 2024, the Company has arranged staking of five new mineral claims for prospective uranium exploration. These five mineral claims are in the Thelon Basin in Nunavut Territory and occupy an area of 5,688ha. The total land area held for exploration by Lexston through the new five claims and the previously announced Project 176 and Project Itza Option Agree

Jan 11, 2024 06:00 pm ET

Lexston Mining Corporation Grants Stock Options

Vancouver, British Columbia – TheNewswire - January 11, 2024. Lexston Mining Corporation (CSE:LEXT) (“Lexston”) granted 1,250,000 stock options to its directors, officers, consultants, and employees.

Jan 10, 2024 07:00 am ET

Issuance of Common Shares Pursuant to the Option Agreement for URANIUM PROJECT 176 and URANIUM PROJECT ITZA in Nunavut

Vancouver, British Columbia – TheNewswire - January 10, 2024 - Lexston Mining Corporation (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces that further to its news release dated November 27, 2023, the Company has issued 1,000,000 common shares and made a $90,000 payment pursuant to the Project 176 and Project Itza Option Agreement dated November 27, 2023 (the “Agreement”). The common shares issued pursuant to the Agreement are subject to a four month and one day statutory hold period.

Nov 27, 2023 02:14 pm ET

Lexston Mining Corporation Announces an Option Agreement for URANIUM PROJECT 176 and URANIUM PROJECT ITZA in Nunavut

Vancouver, British Columbia – TheNewswire - November 27, 2023 - Lexston Mining Corporation (the “Company” or “Lexston”) (CSE:LEXT) (OTC:LEXTF) entered into the Project 176 and Project Itza Option Agreement dated November 27, 2023 (the “Agreement”) with three optionors (the “Optionors”) to acquire 100% interest in the uranium mineral property, generally known as "Project 176" (claim 103470) and “Project Itza” (claim numbers 103463, 103478 and 103465) located in the Thelon Basin in Nunavut and occupying a total area of 5661.93 hectares (the “Property”).

Nov 16, 2023 07:00 am ET

Listing on the Frankfurt Stock Exchange

Vancouver, British Columbia – TheNewswire - November 16, 2023. Lexston Mining Corporation (“Lexston” or the “Company”) (CSE:LEXT) (OTC:LEXTF) is pleased to announce the listing of its common shares on the Frankfurt Stock Exchange ("FSE") under the trading symbol W5G | WKN: A3EXDQ | ISIN:CA52978C1023).

Nov 15, 2023 07:00 am ET

Lexston Mining Corporation Conducting Review and Assessment of Uranium Assets

Vancouver, British Columbia - TheNewswire - November 15, 2023 - Lexston Mining Corporation the “Company”) (CSE:LEXT) (OTC:LEXTF) is pleased to announce the Company is conducting diligence regarding exploration of uranium resources within Canada and the United States.

Nov 08, 2023 12:15 pm ET

Results of Annual General and Special Meeting

Vancouver, British Columbia - TheNewswire - November 8, 2023 - Lexston Mining Corporation (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces the results of its annual general and special meeting held on November 8, 2023. The shareholders of the Company approved all matters described in the Company’s notice of meeting and management information circular dated October 4, 2023.

Oct 23, 2023 01:41 pm ET

Canadian Investment Regulatory Organization Trade Resumption - LEXT

VANCOUVER, BC, Oct. 23, 2023 /CNW/ - Trading resumes in:

Oct 19, 2023 10:30 am ET

Lexston Mining Corporation Announces Completion of the Change of Business and Name Change

Vancouver, British Columbia – TheNewswire - October 19, 2023 - Lexston Mining Corporation the “Company”) (CSE:LEXT) (OTC:LEXTF) is pleased to announce that further to its news releases dated January 18, 2023, and May 21, 2023, the Canadian Securities Exchange (the “CSE”) has accepted the change of business of the Company. Common shares of the Company will resume trading on the CSE on October 23, 2023. The listing statement of the Company provides the particulars of the change of business, will be posted on the CSE website and on “SEDAR+” under the profile of the Company.

Jun 28, 2023 11:10 am ET

Lexston announces change of Auditor

Vancouver, British Columbia – TheNewswire - June 28, 2023 - Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announced today that its board of directors has approved a change of the Company’s auditors. At the request of the Company, Saturna Group Chartered Professional Accountants LLP (the “Former Auditor”) has resigned as auditor of the Company effective June 27, 2023. The audit committee and board of directors of the Company have appointed WDM Chartered Professional Accountants as the successor auditor, effective June 27, 2023 (the “Successor Auditor”) until the close of t

Jun 02, 2023 09:00 am ET

Lexston Life Sciences Corp. filed the Technical Report on the Dory Property

Vancouver, British Columbia – TheNewswire - June 2, 2023 - Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) filed the “NI 43-101 Technical Report on The Dory Property Port Alberni British Columbia Canada” dated March 13, 2023 authored by Derrick Strickland, P. Geo (the “Report”).

May 31, 2023 09:50 am ET

Amendment to the Dory Property Option Agreement

Vancouver, British Columbia – TheNewswire - May 31, 2023 - Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) and the optionor amended the Dory Property Option Agreement dated for reference January 18, 2023 (the “Dory Property Option Agreement”). Pursuant to the amendment (“Amendment 1”), section 3.2 of the Dory Property Option Agreement was replaced with the following text:

Mar 02, 2023 02:15 pm ET

Board of Directors Appointment

Vancouver, BC - TheNewswire - March 2, 2023. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) has appointed Mr. Richard Graham Walker, Jr. to its board of directors and to the audit committee. Mr. Walker is a Certified Professional Geologist, a member of the American Institute of Professional Geologists and a member of the Geological Society of Nevada. He is an independent director.

Feb 24, 2023 02:15 pm ET

Update regarding the Option Agreement for the Dory Property and the Change of Business

Vancouver, British Columbia – TheNewswire - February 24, 2023 - Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) provides an update on the Dory Property Option Agreement dated January 18, 2023 and the change of business announced by the Company’s news release dated January 18, 2023.

Jan 18, 2023 04:03 pm ET

Lexston Life Sciences Corp. Announces the Option Agreement for the Dory Property and a Change of Business

Vancouver, BC - TheNewswire - January 18, 2023 - Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) entered into the Dory Property Option Agreement dated January 18, 2023 (the “Option Agreement”) with Nicholas Rodway (the “Optionor”) to acquire up to 100% interest in the mineral property, generally known as the "Dory Property" consisting of four (4) mineral claims #1098125, #1098126, #1098127 and #1098419 located 25 km west of Port Alberni in British Columbia. The size of the Dory Property is approximately 1,348 hectares. The Dory Property has potential for copper, zinc and

Jan 18, 2023 10:11 am ET

IIROC Trading Halt - LEXT

VANCOUVER, BC, Jan. 18, 2023 /CNW/ - The following issues have been halted by IIROC:

Oct 17, 2022 06:00 am ET

Changes to the Board of Directors

Vancouver, British Columbia – TheNewswire - October 17, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces the resignation of Graeme Staley as a director of the Company effective October 14, 2022. The Company thanks Mr. Staley for his service.

Oct 06, 2022 12:20 pm ET

Correction Regarding Option Grant

Vancouver, British Columbia – TheNewswire - October 6, 2022 - Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces the following correction to its news release dated October 3, 2022.

Oct 03, 2022 06:00 am ET

Lexston Life Sciences Corp. Grants Stock Options

Vancouver, British Columbia – TheNewswire - October 3, 2022. Lexston Life Sciences Corp. (CSE:LEXT), (OTC:LEXTF) (“Lexston”) granted 3,000,000 stock options to its directors, officers, consultants, and employees.

Sep 12, 2022 11:20 am ET

Board of Directors Appointment

Vancouver, British Columbia – TheNewswire - September 12, 2022 - Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces the appointment of Mr. Clinton Sharples as a director of the Company. In addition, Mr. Sharples has joined the audit committee of the Company. The audit committee now consists of Jagdip Bal, Graeme Staley and Clinton Sharples.

Sep 08, 2022 09:00 am ET

Changes to the Board of Directors

Vancouver, British Columbia – TheNewswire - September 8, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces the resignation of Harinder Bains as a director of the Company effective September 7, 2022. The Company thanks Mr. Bains for his service.

Aug 11, 2022 12:28 pm ET

Lexston Announces the Results of its Annual General and Special Meeting

Vancouver, British Columbia – TheNewswire - August 11, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces the results of its annual general and special meeting (“AGSM”). The shareholders approved all matters described in the Company’s notice of meeting and management information circular dated July 11, 2022.

Jul 04, 2022 02:31 pm ET

Lexston closes previously announced Non-Brokered Unit Private Placement

Vancouver, British Columbia TheNewswire - July 4, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces that further to its news releases dated June 1, 2022 and June 27, 2022, the Company has issued 18,562,440 units (“Units”) at a purchase price of $0.05 per Unit for gross proceeds of $928,122 (the “Private Placement”). Each Unit consists of one common share in the capital of the Company (“Share”) and one share purchase warrant (“Warrant”). Each full Warrant entitles the holder to purchase one Share for a period of five years, at a purchase price of $0.075 per

Jun 27, 2022 02:29 pm ET

Lexston increases previously announced Non-Brokered Unit Private Placement

Vancouver, British Columbia – TheNewswire - June 27, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces an increase to the non-brokered private placement announced on June 1, 2022. The Private Placement has been increased to up to 22,000,000 units (the “Units”) at a purchase price of $0.05 per Unit to raise gross proceeds of up to $1,100,000 (the “Private Placement”). Each unit will consist of one common share in the capital of the Company and one share purchase warrant (a “Warrant”). Each full warrant will entitle the holder to purchase one additional commo

Jun 15, 2022 06:50 pm ET

Resignation of Director and Chief Science Officer

Vancouver, British Columbia – TheNewswire - June 15, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces the resignation of Dr. Philippe Henry from his positions as a director and the Chief Science Officer of the Company effective June 15, 2022. The Company thanks Dr. Henry for his service.

Jun 09, 2022 04:15 pm ET

Lexstons Subsidiaries Lay off Staff

Vancouver, British Columbia – TheNewswire - June 9, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces that its subsidiaries Egret Bioscience Ltd. and Zenalytic Laboratories Ltd. (the “Subsidiaries”) will be laying off all their employees effective June 15, 2022. The decision was made due to the lack of profitability and to save costs. Some scientific staff will be available on as needed basis. The Company is planning the future for the Subsidiaries.

Jun 03, 2022 04:49 pm ET

Lexston Announces Non-Brokered Unit Private Placement

Vancouver, British Columbia – TheNewswire - June 3, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces that it has cancelled an aggregate of 796,000 incentive stock options (the “Cancelled Options”) previously held by certain directors, officers, employees, and consultants of the Company. The Cancelled Options were comprised of the following:

Jun 01, 2022 03:22 pm ET

Lexston Announces Non-Brokered Unit Private Placement

Vancouver, British Columbia – TheNewswire - June 1, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) announces a non-brokered private placement consisting of up to 15,000,000 units (the “Units”) at a purchase price of $0.05 per Unit to raise gross proceeds of up to $750,000 (the “Private Placement”). Each unit will consist of one common share in the capital of the Company and one share purchase warrant (a “Warrant”). Each full warrant will entitle the holder to purchase one additional common share in the capital of the Company for a period of five years, at a purchas

May 20, 2022 05:29 pm ET

CSE Bulletin: Consolidation - Lexston Life Sciences Corp. (LEXT)

Toronto, Ontario--(Newsfile Corp. - le 20 mai/May 2022) - Lexston Life Sciences Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every five (5) pre-consolidated common shares.

May 20, 2022 02:50 pm ET

Share Consolidation

Vancouver, British Columbia – TheNewswire - May 20, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE:LEXT) (OTC:LEXTF) is providing the following update regarding its common share consolidation announced on May 13, 2022.

May 13, 2022 03:45 pm ET

LEXSTONS Directors Approve Five to One Share Consolidation

Vancouver, British Columbia – TheNewswire - May 13, 2022. Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (OTC:LEXTF) announces that its board of directors approved the consolidation of the common shares of the Company on the ratio of five (5) pre-consolidated shares for one (1) post-consolidated share. The effective date and timing of the share consolidation will be determined and announced at a later date.

Apr 11, 2022 07:00 am ET

Lexston Life Sciences funds whole genome sequencing project for Psilocybe allenii, an understudied psychedelic mushroom native to the Pacific Northwest

Vancouver, British Columbia - TheNewswire - April 11, 2022 - Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (CNSX:LEXT.CN) (OTC:LEXTF) a biotechnology company focused on the development of analytical services and production of botanically derived psychedelics, is pleased to announce that, on April 4, 2022, its wholly-owned subsidiary, Egret Bioscience Ltd., sponsored the whole genome sequencing, open access archiving and biobanking of the Pacific Northwest wood-rotting psychedelic mushroom, Psilocybe allenii.

Mar 25, 2022 02:40 pm ET

LEXSTON LIFE SCIENCES CORP. Appoints CFO, Makes Changes to the Audit Committee

Vancouver, British Columbia – TheNewswire - March 25, 2022. Lexston Life Sciences Corp. (CSE:LEXT) (the “Company” or “Lexston”) announces the resignation of Dimitrios Mitrakos as the Chief Financial Officer and Corporate Secretary of the Company and the appointment of Company’s director Jatinder Jesse Manhas as the Chief Financial Officer and Corporate Secretary of the Company.

Jan 31, 2022 06:00 am ET

Lexston Life Sciences is Granted Section 56 Exemption from Health Canada and embarks on the development of portable technology for quantification and traceability of Psilocybe mushrooms

Vancouver – TheNewswire - British Columbia, January 31, 2022. Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (CNSX:LEXT.CN) (OTCQB:LEXTF) a biotechnology company focused on the development of analytical services and production of botanically derived psychedelics, is pleased to announce that, on January 17, 2022, its wholly-owned subsidiary, Egret Bioscience Ltd., was granted a two year long Section 56 exemption by Health Canada, pursuant to which the company can now possess up to 100 grams of psilocybin mushrooms for scientific purposes for their project entitled “Establi

Jan 24, 2022 06:30 am ET

Lexston Announces The Launch Of A Psychedelic Mushrooms Genetic Identification Test

Vancouver, British Columbia - TheNewswire - January 24, 2022 - Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (CNSX:LEXT.CN) (OTC:LEXTF) is pleased to announce that the Company’s wholly owned subsidiary, Egret Bioscience Ltd. (“Egret”) has developed and validated a targeted genetic barcode consisting of eight Single Nucleotide Polymorphism (“SNP”) for psychedelic mushroom genetic identification (“Egret Psilocybe Assay”). Egret has previously developed and published similar genetic identification tests for the Cannabis Industry (https://t.co/rh1VJ5cf0a) and have been offe

Jan 19, 2022 04:00 am ET

Lexston Announces Federal Funding for Cannabis Transformation Project That Will Result in Zero THC Varieties.

Vancouver, British Columbia – TheNewswire - January 19, 2022. Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (CNSX:LEXT.CN) (OTCQB:LEXTF) is pleased to announce that the company’s wholly owned subsidiary, Egret Bioscience Ltd. (“Egret”) has recently received funding from the Canadian government for their project on Cannabis transformation to develop new breeding techniques using CRISPR-Cas9 technology.

Jan 14, 2022 04:00 pm ET

Lexston Comments On Recent Market Activity

Vancouver, British Columbia – TheNewswire - January 14, 2022. Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (CNSX:LEXT.CN) (OTC:LEXTF) wishes to make the following statements regarding certain market activity surrounding its common shares (the” Shares”) traded on the OTCQB market pursuant to the request of OTC Markets Group Inc. (“OTC Markets”).

Jan 12, 2022 06:30 am ET

Lexston Announces a Memorandum Of Understanding to Collabborate on Psychedelics Research and Development with Alvarius Research Inc.

Vancouver, British Columbia – TheNewswire - January 12, 2022. Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (CNSX:LEXT.CN) (OTC:LEXTF) is pleased to announce the signing of a Memorandum of Understanding (the “MOU”) between its wholly owned subsidiary Egret Bioscience Ltd. (“Egret”) and Alvarius Research Inc. (“Alvarius”; a wholly owned subsidiary of Lighthouse Genomics Inc.), a leading research and development company focused on ex situ conservation and genomic resource development for the Colorado River toad (Incilius alvarius).

Jan 10, 2022 06:30 am ET

Lexston Announces a Memorandum of Understanding with United States Based Panacea Plant Sciences Inc. for Research and Development of Psychedelics and Cannabis

\Vancouver, British Columbia - TheNewswire - January 10, 2022 - Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (CNSX:LEXT.CN) (OTC:LEXTF) is pleased to announce the signing of a Memorandum of Understanding (the “MOU”) between its wholly owned subsidiary Egret Bioscience Ltd. (“Egret”) and Panacea Plant Sciences Inc. (“Panacea”), a leading United States biotechnology company focused on developing new therapeutic, cultivation, extraction and isolation techniques for high value natural products such as psychedelic-containing lifeforms and cannabis.

Dec 15, 2021 07:00 am ET

Lexston Life Sciences Corp. announces DTC Eligibility

Vancouver, British Columbia - TheNewswire - December 15th, 2021 - Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (CNSX:LEXT.CN) (OTC:LEXTF) is pleased to announce that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC") in the United States.

Nov 15, 2021 09:00 am ET

Lexston Life Sciences Corp. Announces Upgrade to OTCQB Market in the United States

Vancouver, British Columbia – TheNewswire - November 15, 2021 - Lexston Life Sciences Corp. (CSE:LEXT) (CNSX:LEXT.CN) (OTC:LEXTF) (the “Company” or “Lexston”) is pleased to announce that after successfully completing the application process, the Company has received approval from OTC Markets Group Inc. for its common shares to begin trading on the OTCQB Market ("OTCQB") beginning at market open on November 12, 2021 under the symbol "LEXTF". The Company's common shares will remain listed on the CSE in Canada under the ticker symbol "LEXT".

Nov 11, 2021 04:40 pm ET

Lexston Life Sciences Corp. Grants Stock Options

Vancouver, British Columbia – TheNewswire - November 11, 2021. Lexston Life Sciences Corp. (CSE:LEXT) (CNSX:LEXT.CN) (“Lexston”) granted 1,400,000 stock options to its directors, officers, consultants and employees.

Sep 28, 2021 05:50 am ET

Lexston Life Sciences Corp. Congratulates Psy Integrated Health Inc.

Vancouver, British Columbia - TheNewswire - September 28, 2021 - Lexston Life Sciences Corp. (CNSX:LEXT.CN) (OTC:LEXTF) (the “Company” or “Lexston”) is pleased to announce that further to the news of July 7th, 2021 announcing the acquisition of 750,000 Class C Non-Voting Common Shares for a total of 13% ownership of Psy Integrated Health Inc. (“Psy Integrated”), Psy Integrated has celebrated their grand opening of its state of the art health and wellness center, Empower Health Clinic, in Vancouver, British Columbia on September 18, 2021.

Sep 23, 2021 05:45 am ET

Lexston Initiates Research and Development Project Using Psychedelic Compound 5-Me0-DMT

Vancouver, British Columbia - TheNewswire - September 23, 2021 - Lexston Life Sciences Corp. (CNSX:LEXT.CN) (the “Company” or “Lexston”) is pleased to announce that the company’s scientific research and development division led by Chief Science Officer, Dr. Philippe Henry, has begun work on its tryptamine pipeline with an initial focus on 5-Methoxy-N, N-dimethyltryptamine (5-MeO-DMT) at its newly acquired Zenalytic Laboratories.

Sep 21, 2021 05:50 am ET

Lexston Life Sciences Corp. Acquires Zenalytic Laboratories Ltd.

Vancouver, British Columbia, September 21, 2021. Lexston Life Sciences Corp. (CSE: LEXT) (the “Company” or “Lexston”) is pleased to announce the acquisition of Zenalytic Laboratories Ltd. (“Zen Labs”), a wholly owned subsidiary of Avant Brands Inc. (“Avant”), which is a publicly listed issuer on the Toronto Stock Exchange (TSX: AVNT).

Sep 21, 2021 05:50 am ET

Lexston Life Sciences Corp. Acquires Zenalytic Laboratories Ltd.

Vancouver, British Columbia – TheNewswire - September 21, 2021 - Lexston Life Sciences Corp. (CSE:LEXT) (CNSX:LEXT.CN) (the “Company” or “Lexston”) is pleased to announce the acquisition of Zenalytic Laboratories Ltd. (“Zen Labs”), a wholly owned subsidiary of Avant Brands Inc. (“Avant”), which is a publicly listed issuer on the Toronto Stock Exchange (TSX: AVNT).

Sep 09, 2021 06:00 am ET

Lexston Life Sciences Corp. retains marketing consultants and sets Stock Options

Vancouver, British Columbia - TheNewswire - September 9, 2021 - Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CNSX:LEXT.CN) is pleased to announce that the Company has retained Amherst Baer Consultancy Corp. (ABCC”), of Langley, British Columbia, to prepare a marketing campaign for the Company.

Jul 13, 2021 06:07 am ET

Lexston Life Sciences Corp. Health Canada Section 56 Exemption Application

Vancouver, British Columbia - TheNewswire - July 13, 2021 - Lexston Life Sciences Corp. (CNSX:LEXT.CN) (the “Company” or “Lexston”) is pleased to announce that on July 9, 2021, the Company received an update from Health Canada, that the application of its wholly owned subsidiary Egret Bioscience Ltd. (“Egret”) submitted to Health Canada for an exemption to use a controlled substance for scientific purposes, pursuant to Section 56(1) of the Controlled Drugs and Substances Act, S.C. 1996, c. 19 (a "Section 56 Exemption") has been screened and sent to the Office of Controlled Substances. Lexsto

Jul 07, 2021 07:07 am ET

Lexston Life Sciences Corp. Makes an Investment Into Psy Integrated Health Inc.

Vancouver, British Columbia - TheNewswire - July 7, 2021 - Lexston Life Sciences Corp. (CNSX:LEXT.CN) (the “Company” or “Lexston”) is pleased to announce an acquisition of 750,000 Class C Non- Voting Common Shares of Psy Integrated Health Inc. (“Psy Integrated”) for the total consideration of $75,000 representing 13% of the total issued and outstanding shares of Psy Integrated.

Jul 05, 2021 02:07 am ET

Lexston Life Sciences Corp. Grants Stock Options

Vancouver, British Columbia – TheNewswire - July 5, 2021 - Lexston Life Sciences Corp. (CSE:LEXT) (CNSX:LEXT.CN) (“Lexston”) granted 2,500,000 stock options to its directors, officers, consultants and employees.

Jun 30, 2021 06:06 am ET

Lexston Life Sciences Corp. Appoints Graeme Staley to its Board of Directors

Vancouver, British Columbia – TheNewswire - June 30, 2021 - Lexston Life Sciences Corp. (CSE:LEXT) (CNSX:LEXT.CN) (the “Company” or “Lexston”) is pleased to announce the appointment of Mr. Graeme Staley to its board of directors.

Jun 23, 2021 04:12 pm ET

CSE Bulletin: New Listing - Lexston Life Sciences Corp. (LEXT)

Toronto, Ontario--(Newsfile Corp. - Le 23 juin/June 2021) The common shares of Lexston Life Sciences Corp. have been approved for listing on the CSE.

Jun 23, 2021 11:06 am ET

Lexston Life Sciences Corp. Announces Listing of its Common Shares on the Canadian Securities Exchange

Vancouver, British Columbia – TheNewswire - JUNE 23, 2021 - Lexston Life Sciences Corp. (the “Company”) (CNSX:LEXT.CN) is pleased to announce that its common shares will commence trading at market open on June 25, 2021 on the Canadian Securities Exchange under the stock symbol “LEXT”.

You are here

Lexston Mining Corporation (C:LEXT*CA)

Business Focus: Diversified Mining